Advisory Research Inc Abiomed Inc Transaction History

Advisory Research Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$276.39 - $362.25 $401,318 - $525,987	-1,452 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$281.08 - $444.25 $61,275 - $96,846	218 Added 17.67%	1,452 $472,000
Q3 2018 Nov 13, 2018	SELL	$354.53 - $449.75 $169,465 - $214,980	-478 Reduced 27.92%	1,234 $555,000
Q2 2018 Aug 14, 2018	BUY	$278.07 - $446.21 $556 - $892	2 Added 0.12%	1,712 $700,000
Q1 2018 May 15, 2018	SELL	$192.49 - $295.85 $320,495 - $492,590	-1,665 Reduced 49.33%	1,710 $498,000
Q4 2017 Feb 08, 2018	SELL	$168.78 - $199.74 $1.58 Million - $1.87 Million	-9,344 Reduced 73.46%	3,375 $633,000
Q3 2017 Nov 14, 2017	BUY	$145.39 - $168.6 $1.85 Million - $2.14 Million	12,719	12,719 $2.14 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.